46
Participants
Start Date
January 31, 2003
Primary Completion Date
March 31, 2005
Study Completion Date
March 31, 2005
omega-3 polyunsaturated fatty acids ( EPA+DHA)
Group 1 received omega-3 PUFAs as 3 capsules twice daily (total daily omega-3 fatty acid dosage of 1080 mg of EPA and 720 mg of DHA). Group 2 received three identical placebo capsules twice daily which contained olive oil esters. Identical gelatin capsules were used. Both treatment and placebo capsules were vacuum deodorized and supplemented with tertiary-butyl hydroquinone, 0.2 mg/g, and tocopherols, 2 mg/g, as antioxidants. The source of the omega-3 fatty acids was menhaden fish body oil concentrate.
Taipei City Psychiatric Center, Taipei City Hospital, Taipei
Department of Health, Executive Yuan, R.O.C. (Taiwan)
OTHER_GOV
Taipei City Psychiatric Center, Taiwan
OTHER